Type II Medical Device Manufacturing and Sales Business license from the Tokyo Metropolitan Government as of November 13, 2025.

Dec 5, 2025
1 min read

Southwood Inc. otained a “Type II Medical Device Manufacturing and Sales License” from the Tokyo Metropolitan Government on November 13, 2025.

This enables us to manufacture and sell program-based medical devices, including medical AI, up to Class II.

■License Information

Manufacturing Facility Name：Southwood Co., Ltd.

Manufacturing Facility Address：1 Bancho, Chiyoda-ku, Tokyo

Registration Number：13B2X10646

■Contact for Inquiries Regarding This Matter

info@southwood.co.jp

Comments

We Have Obtained “Certification for a Designated Specially Controlled Medical Device.”

On March 11, 2026, our company obtained the “Certification of Designated Specially Controlled Medical Devices.” We are dedicated to accelerating the integration of AI-assisted ultrasound diagnostics into the healthcare system. ■ Details of the “Certification of Designated Specially Controlled Medical Devices.” Certification Number: 308ACBZX00005000 Marketing Authorization Holder: Southwood Inc. Certified Product: Ultrasound Image Display Software “Southwood” Certification Dat

4 days ago

A Pilot Study on Remote Ultrasound Using the “Butterfly iQ3™” Was Conducted

Southwood Inc. (Headquarters: Tokushima City, Tokushima Prefecture; Representative Director: Kenya Kusunose), a licensed distributor of the portable ultrasound diagnostic device “Butterfly iQ3™” manufactured by Butterfly Network, Inc. (U.S.), conducted a remote echocardiography demonstration (pilot study) on March 6, 2026, at University of the Ryukyus Hospital and Okinawa Prefectural Yaeyama Hospital, with real-time connectivity between both locations. In this pilot study of

Mar 17

We Have Obtained a Secondhand Goods Dealer License

Mar 17

We Have Obtained ISO/IEC 27001 Certification

Our company has obtained certification for the international standard ISO/IEC 27001, which relates to Information Security Management Systems (ISMS), on March 3, 2026. ISO/IEC 27001 is an international standard that provides a framework for organizations to effectively manage information by ensuring an appropriate balance of confidentiality, integrity, and availability, thereby enabling the secure and efficient use of information. We will continue to appropriately manage ou

Mar 11

We Will Participate in “DEEPTECH STARTUP PITCH in TOKYO” Hosted by Tokushima Prefecture

Our company will participate in the “DEEPTECH STARTUP PITCH in TOKYO,” which will be held in Tokyo on Thursday, March 12, 2026. ■ Event Overview “DEEPTECH STARTUP PITCH in TOKYO” is a pitch event where Tokushima Prefecture’s leading deep-tech startups present their technologies and future potential to investors and organizations seeking new investment and collaboration opportunities. This event offers a firsthand look at the forefront of innovation emerging from Tokushima, as

Feb 13

A Study Session Using the “Butterfly iQ3™” Was Held at Okayama University

Southwood Co., Ltd. (Headquarters: Tokushima City, Tokushima Prefecture; President: Kenya Kusunose), an authorized distributor, hosted a study session using the portable ultrasound imaging device “Butterfly iQ3™,” manufactured by Butterfly Network, Inc. (USA). The session, organized by the Regional Medical Personnel Development Program, was held at Okayama University on January 17, 2026. Physicians, residents, and students involved in regional healthcare participated in hands

Feb 10